October 2020 Episode
Black women speak out regarding their research, insight, and experience with Uterine Fibroids and its factor in pregnancy loss and mental health challenges.
Hosted & Sponsored by
S. Denise Johnson Foundation Inc
Notes & References
Uterine Fibroids are the most common disease of reproductive-age women, affecting 25% of African American women at the age of 251 and up to 80% African American women by the age of menopause.2,3 Although it is clear that uterine fibroids are a health disparity issue4, they affect women of all races and add billions of dollars in cost each year to the US health care system. Globally as well, uterine fibroids are among the most significant diseases of reproductive-age women. Despite the magnitude of the problem, nonsurgical and medical options for treatment are extremely limited.
One reason for the limited treatment options is that funding for research on uterine fibroids has been sparse in comparison to the scope of the problem. Uterine fibroids are wholly deserving of research effort because investments will also inform the disciplines and fields of: tumor biology, angiogenesis, mechanical signaling, fibrosis, and genetics.
Excerpt from –
Segars, James H. “Uterine fibroid research: a work in progress.” Reproductive sciences (Thousand Oaks, Calif.) vol. 21,9 (2014): 1065-6. doi:10.1177/1933719114546644
In the News
Sen. Kamala Harris Introduces Bill on Uterine Fibroids